Skip Navigation



QJM Advance Access published online on July 22, 2006

QJM, doi:10.1093/qjmed/hcl073
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/8/531    most recent
hcl073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jakob, F.
Right arrow Articles by Cooper, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jakob, F.
Right arrow Articles by Cooper, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: Journals.permissions@oxfordjournals.org
Received March 14, 2006
Accepted May 5, 2006

Original Papers

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

F. Jakob 1, F. Marín 2, E. Martín-Mola 3, D. Torgerson 4, P. Fardellone 5, S. Adami 6, N.C. Thalassinos 7, D. Sykes 2, J. Melo-Gomes 8, C. Chinn 2, T. Nicholson 2, and C. Cooper 9 *

1 From the Orthopaedic Department, Julius-Maximilians-Universität, Wurzburg, Germany
2 From the Lilly Research Center, Erl Wood Manor, Windlesham, UK
3 From the Servicio de Reumatología, Hospital La Paz, Madrid, Spain
4 From the Department Health Sciences, University of York, York, UK
5 From the Service de Rhumatologie, Hôpital Nord, Amiens, France
6 From the University of Verona, Centro Ospedaliero Clinicizzatodi Valeggio sul Mincio, Verona, Italy
7 From the Department of Endocrinology, Diabetes and Metabolism, Evangelismos General Hospital, Athens, Greece
8 From the Instituto Portugues de Reumatologia, Lisbon, Portugal
9 From the MRC Epidemiology Resource Centre, Southampton General Hospital, Southampton, UK

* To whom correspondence should be addressed.
C. Cooper, E-mail: cc{at}mrc.soton.ac.uk


   Abstract

Background: Osteoporotic fractures remain a major public health problem. Currently available osteoporosis therapies significantly reduce the risk of fractures, but up to 50% of patients have an inadequate clinical outcome to therapy.

Aim: To describe the clinical and quality of life (QOL) of a study population meeting a proposed definition of inadequate clinical outcome to osteoporosis therapy, recruited for the Observational Study of Severe Osteoporosis (OSSO).

Design: Cross-sectional, observational study.

Methods: Post-menopausal women with osteoporosis (n = 2314) were divided into Group 1 (those who had previously experienced a fragility fracture despite osteoporosis drug therapy for at least 12 months) (n = 1309, 57%), or Group 2 (those who had previously discontinued osteoporosis drug therapy due to non-compliance or side-effects) (n = 1005; 43%). Baseline clinical characteristics, quality of life (QOL) and osteoporosis/falls risk factors were analysed.

Results: The overall population had low BMD (mean ± SD T-score at lumbar spine -3.1 ± 1.1), and risk factors for fracture such as previous fractures (67.8%), family history (15.1%), and prolonged glucocorticoid use (17.5%). QOL was poor: total QUALEFFO and EQ-5D scores were 46.8 ± 18.7, and 0.50 ± 0.33, respectively. Patients in Group 1 had higher age and body mass index, fewer hours of exercise, more previous fragility fractures and falls, and poorer QOL scores.

Discussion: Our definition of inadequate clinical outcome from osteoporosis drug therapy identifies a severe osteoporosis cohort with poor QOL and increased fracture risk. Using such a definition may lead to earlier recognition of inadequate clinical outcome to osteoporosis therapy, and improved interventions and results.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.